alter nuclear P-p65 levels in FC. These results suggest that olanzapine exerts some anti-inflammatory properties which may contribute to its therapeutic effects and/or toxicity.
Abstract
Introduction: Gene-environmental interaction has been implicated in the pathogenesis of various mental disorders. Recent genome-wide association studies revealed that shared genetic polymorphisms underlie the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ). Accumulating evidence suggests that epigenetic factors, which reflect the environmental insults and play a role in the regulation of long-lasting gene expression patterns, are involved in the pathophysiology of BD and SZ. However, it has not been fully studied whether epigenetic factors are shared or distinctive between BD and SZ. Recently, a large-scale methylome-wide association study (MWAS) was performed in peripheral blood of SZ. Here we performed pyrosequencing-based DNA methylation assays of the top five regions detected in the MWAS using peripheral blood of BD. Methods: The sample consisted of peripheral blood of 448 BD patients and 458 healthy controls (CT) collected in Japan. We analyzed DNA methylation levels of the top five regions (FAM63B, ARHGAP26, CTAGE11P, TBC1D22A and intergenic region in chromosome 16 (ch16)), which showed hypomethylation in SZ, by pyrosequencing. Results: Among the five regions, significant differences of DNA methylation level between BD and CT were detected in the three regions; FAM63B, TBC1D22A and intergenic region in ch16. Detailed analysis focusing on sex revealed the hypomethylation in intergenic region in ch16 in both male and female BD, and hypomethylation in FAM63B in male BD. On the other hand, we identified hypermethylation of the CpG sites in TBC1D22A in female BD. Discussion: Hypomethylation of FAM63B, which is part of the networks regulated by microRNA that can be linked to neuronal differentiation and dopaminergic gene expression as well as intergenic region in chr16, may be common epigenetic alterations between SZ and BD. On the other hand, DNA methylation level of TBC1D22A may be linked to disease-dependent epigenetic alteration. Conclusion: We identified common and distinctive epigenetic alterations between BD and SZ. These findings help to understand the pathophysiology of mental disorders and may contribute to develop the epigenetic-based biomarker using peripheral blood samples. Key Words: schizophrenia, bipolar disorder, DNA methylation, epigenetic biomarker
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Long term efficacy and tolerability of lamotrigine for patients with bipolar disorder;A retrospective study Abstract Objective: Although lamotrigine has been widely used in bipolar disorders in many countries, in Japan, it was approved for bipolar disorders at July 2011. This study was conducted to investigate the long term efficacy and tolerability of lamotrigine. Method: The subjects were 91 patients who were diagnosed as bipolar disorder(type1:n=40, type2;n=51) and treated with lamotrigine from Jan 2012 to Aug 2014 in our psychiatric hospital. We retrospectively investigated the clinical efficacy, safety and 52-week-continuation rate of lamotrigine, and also the relating clinical factors such as age, gender, diagnosis(type1 or 2), clinical state(depressive/manic/mixed), dose, concomitant psychotropic medication. We evaluated the efficacy as clinical global impression of improvement (CGI-I). Patients with a score of minimally (3), much (2) or very much improved (1) were considered as responders. Results: Although the response rate of lamotirigine was 72.2 % for the patients with depressive and mixed state, The patients with type 2 bipolar disorders showed higher response rate than that with type 1(78.4% vs 60.0%). Main side effect was skin rash (16.5 %). The total 52-week continuation rate was 58.1 %. The main cause of discontinuation was mucocutaneous symptoms at early phase (almost within 8 week) and following cause was lack of insight. The continuation rate in the patients with depressive and euthymic state was higher than those with mixed and manic state(66.2% vs 21.4%). Conclusion: Lamotrigine was effective and well tolerable, especially for type 2 bipolar disorder. The management of the side effect as mucocutaneous symptoms and psychoeducation might be necessary to increase the long term continuation rate.
